CD19 and acute lymphoblastic leukemia: In their first article,1 the authors studied safety and efficacy of anti-CD19 CAR-T-cells in persons with advanced B-cell acute lymphoblastic leukemia (ALL) with synchronous central nervous system (CNS) leukaemia (NCT02782351 and ChiCTR-OPN-16008526) (1).